Heparin-Related Major Bleeding in Covid-19-Positive Patient: Perspective from the Outbreak
Open Access
- 1 August 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in CardioVascular and Interventional Radiology
- Vol. 43 (8), 1216-1217
- https://doi.org/10.1007/s00270-020-02532-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A commentJournal of Thrombosis and Haemostasis, 2022
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- The versatile heparin in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective studyBMJ, 2020
- Safe patient transport for COVID-19Critical Care, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020